The DOI matches its Crossref record; 39 of the 39 references it cites were found in a registry or an index; 8 of the 30 sources its claims cite were checked for support.
The effect of the mobile “blood pressure management application” on hypertension self-management enhancement: a randomized controlled trial
Open accessPublished version of a preprint
Abstract
BACKGROUND: Self-management of hypertension is of great significance given its increasing incidence and its associated disabilities. In view of the increased use of mobile health in medicine, the present study evaluated the effect of a self-management application on patient adherence to hypertension treatment. METHODS: This clinical trial was performed on 120 hypertensive patients who were provided with a mobile intervention for 8 weeks and followed up until the 24th week. Data on the primary outcome (adherence to treatment) and secondary outcomes (adherence to the DASH diet, regular monitoring of blood pressure, and physical activity) were collected using a questionnaire and a mobile application, respectively. The inter-group change difference over time was analyzed using repeated measures ANOVA (general linear model). RESULTS: The treatment adherence score increased by an average of 5.9 (95% CI 5.0-6.7) in the intervention group compared to the control group. The scores of "adherence to the low-fat and low-salt diet plans" were 1.7 (95% CI 1.3-2.1) and 1.5 (95% CI 1.2-1.9), respectively. Moreover, moderate physical activity increased to 100.0 min (95% CI 61.7-138.3) per week in the intervention group. CONCLUSION: The treatment and control of blood pressure require a multifaceted approach given its complexity and multifactorial nature. Considering the widespread use of smartphones, mHealth interventions can be effective in self-management and better patient adherence to treatments. Our results showed that this application can be used as a successful tool for hypertension self-management in patients attending public hospitals in developing countries. TRIAL REGISTRATION: Iran Randomized Clinical Trial Center IRCT2015111712211N2 . Registered on 1 January 2016.
Overview
CoChat Summary
TL;DR
This randomized controlled trial evaluated a mobile Blood Pressure Management Application (BPMAP) added to routine care in 120 Iranian adults with primary hypertension. Over 24 weeks, the intervention improved medication adherence, diet adherence, blood pressure, and physical activity compared with usual care.
Key findings
- Medication adherence on the Hill-Bone Scale improved by 5.9 points (95% CI 5.0–6.7) in the intervention group compared with the control group.
- Adherence to low-fat and low-salt diet plans increased by 1.7 points (95% CI 1.3–2.1) and 1.5 points (95% CI 1.2–1.9), respectively.
- Moderate physical activity increased by 100.0 min per week (95% CI 61.7–138.3), and mean arterial pressure decreased by 3.4 mmHg (95% CI 1.6–5.2) in the intervention group compared with control.
- Among app users, 84.7% (50 people) recorded blood pressure more than 25 times over 2 months; mean satisfaction with the app was 18.41 on a 1–20 scale.
Methods
- Randomized, controlled clinical trial with two parallel arms; 120 patients with primary hypertension, aged 30–60, attending Tehran Heart Center in Iran, were allocated 1:1 using permuted block randomization (block size 4).
- Intervention participants received BPMAP plus routine treatment; control participants received usual care. Follow-up included visits at 2-week intervals and final assessment at 24 weeks, with outcomes measured at baseline, 8 weeks, and 24 weeks.
- Primary outcome was antihypertensive medication adherence measured by the 14-item Hill-Bone Scale; secondary outcomes included DASH diet adherence, sodium/fat intake, blood pressure monitoring, physical activity, and PRECEDE factors. Analysis used repeated measures ANOVA/general linear model adjusted for baseline scores in SPSS 20.0.
Limitations
- The authors state the study was not blinded, relied on self-report questionnaires and app-recorded measurements, and required participants to own an Android smartphone.
- The authors also note that positive attitudes among consultant physicians or participants toward the app could have inclined them to detect or express positive results.
- The text makes evident that two intervention participants were lost to follow-up due to emigration and irregular attendance, and baseline characteristics show some between-group differences (e.g., mean arterial pressure 108.0 vs 114.9 mmHg; cholesterol 179.8 vs 196.7 mg/dl).
Model-written summary. Check it against the paper before relying on it.
Integrity signals
Registry
Cites
Statistics
Figures
Verification
Claims the paper makes
6 Valid · 0 Not valid · 11 Not checked · 39 Own results and interpretations
The sources with a verdict support this claim; the rest weren’t checked yet, have no full text we could read, or their verdicts aren’t rated yet.
In the paper
“Evidence suggests that 65% of mHealth studies have increased adherence to drug therapy and in some cases have been able to increase patients’ self-efficacy and self-care by sending encouraging messages [27, 28].”
§ The effect of the mobile “blood pressure management application” on hypertension self-management enhancement: a randomized controlled trial > Discussion
What the sources say
- Supportedcites [27] Anglada-Martinez H, Riu-Viladoms G, Martin-Conde M, Rovira-Illamola M, Sotoca-Momblona J, Codina-Jane C. Does mHealth increase adherence to medication? Results of a systematic review. Int J Clin Pract. 2015;69(1):9–32. https://doi.org/10.1111/ijcp.12582. source
The Abstract and Conclusion of our copy state that mHealth use 'do seem to have been beneficial, as 65% of the studies found had positive outcomes', and the Discussion (p. ~19) makes the same point in adherence terms: 'the fact that adherence rates significantly improve in 65% of the studies'. This matches the quoted attribution (65% of mHealth studies increasing adherence to drug therapy) in the systematic review's own population of mobile-SMS/app medication-adherence studies. The sentence's trailing self-efficacy/self-care clause is only loosely echoed in our copy ('mHealth can motivate patients and healthy individuals to participate in their own care'; messages carrying 'motivational and reinforcement content'), but the part quoted as attributed to this source is the 65% figure, which is stated verbatim. (LLM, conf=0.90)
- Not checked yetcites [28] Faridi Z, Liberti L, Shuval K, Northrup V, Ali A, Katz DL. Evaluating the impact of mobile telephone technology on type 2 diabetic patients’ self-management: the NICHE pilot study. J Eval Clin Pract. 2008;14(3):465–9. https://doi.org/10.1111/j.1365-2753.2007.00881.x. source
hedgedstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Supported
The sources with a verdict support this claim; the rest weren’t checked yet, have no full text we could read, or their verdicts aren’t rated yet.
In the paper
“A similar finding was found in studies conducted in the UK [32] and Taiwan [33].”
§ The effect of the mobile “blood pressure management application” on hypertension self-management enhancement: a randomized controlled trial > Discussion
What the sources say
- Supportedcites [32] Prestwich A, Perugini M, Hurling R. Can implementation intentions and text messages promote brisk walking? A randomized trial. Health Psychol. 2010;29(1):40–9. https://doi.org/10.1037/a0016993. source
The cited work is a UK-based randomized trial (title page: Andrew Prestwich, Institute of Psychological Sciences, University of Leeds, UK; Robert Hurling, Unilever Corporate Research, Bedford, UK; abstract keyword list opens with 'UK'; participants paid £15 and screened against Department of Health UK guidelines, Recruitment section). Its Discussion (p. 1, opening paragraph) and the primary-outcome Results passage state that implementation intentions paired with SMS plan or goal reminders significantly increased the number of days of self-reported brisk/fast walking for 30 minutes relative to control (d = .49 and .45), i.e. a physical activity increase — exactly the identification the citing sentence offers this citation for. The paper frames the evidence as 'preliminary', but the reported increase itself is stated as a significant finding, so the paraphrase is supported. (LLM, conf=0.88)
- Not checked yetcites [33] Liu W, Wang C, Lin H, Lin S, Lee K, Lo Y, et al. Efficacy of a cell phone-based exercise programme for COPD. Eur Respir J. 2008;32(3):651–9. https://doi.org/10.1183/09031936.00104407. source
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Supported
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“Reducing hypertension and maintaining it in the normal range can prevent its irreparable complications [6].”
§ The effect of the mobile “blood pressure management application” on hypertension self-management enhancement: a randomized controlled trial > Background
What the sources say
- Partly supportedcites [6] Lackland DT, Roccella EJ, Deutsch AF, Fornage M, George MG, Howard G, Kissela BM, Kittner SJ, Lichtman JH, Lisabeth LD, Schwamm LH, Smith EE, Towfighi A, American Heart Association Stroke Council, Council on Cardiovascular and Stroke Nursing, Council on Quality of Care and Outcomes Research, Council on Functional Genomics and Translational Biology. Factors influencing the decline in stroke mortality: a statement from the American Heart Association/American Stroke Association. Stroke. 2014;45(1):315–53. https://doi.org/10.1161/01.str.0000437068.30550.cf. sourceExperimental — accuracy not yet measured
The Clinical trials section (page not available) reports that treating hypertension and lowering blood pressure reduce stroke, myocardial infarction, and heart-failure risks. It does not establish that blood pressure must be maintained in the normal range to obtain those benefits, or characterize the complications as irreparable; it says risk improves even when blood-pressure control levels are not achieved. (LLM, conf=0.85)
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Partly supported
None of the sources cited for this claim have been checked yet.
In the paper
“However, most of these studies have used text messages and notifications only [28, 29].”
§ The effect of the mobile “blood pressure management application” on hypertension self-management enhancement: a randomized controlled trial > Discussion
What the sources say
- Not checked yetcites [28] Faridi Z, Liberti L, Shuval K, Northrup V, Ali A, Katz DL. Evaluating the impact of mobile telephone technology on type 2 diabetic patients’ self-management: the NICHE pilot study. J Eval Clin Pract. 2008;14(3):465–9. https://doi.org/10.1111/j.1365-2753.2007.00881.x. source
- Could not verifycites [29] Contreras EM, Von Wichmann MF, Guillen VG, Ylla-Catala A, Figueras M, Balana M, et al. Effectiveness of an intervention to provide information to patients with hypertension as short text messages and reminders sent to their mobile phone (HTA-Alert). Aten Primaria. 2004;34(8):399–407. sourceExperimental — accuracy not yet measured
Our copy is a single primary RCT (Aten Primaria 2004;34(8):399-407), not a review of mHealth modalities: nowhere does it characterise what technologies 'most' mobile-health studies have used. Its 'Intervención' section describes only its own trial (written HTA information plus a subscription to periodic SMS-type alerts, 2 messages/week for 6 months), and the Introduction/'Mediciones principales' states that SMS had been used as support for young asthma patients (ref 9, Neville et al.) and that 'No existe ningún trabajo publicado que evalúe la efectividad de una intervención sobre el cumplimiento mediante mensajes de alerta en el teléfono móvil' — i.e. it treats alert-message studies as absent/rare rather than surveying the field. Searched: 'most mHealth studies text messages notifications', 'SMS / mensajes cortos / mensajes de alerta', 'discusión estudios previos tecnología móvil', 'Tortajada Raigal estudios antes mencionados'; the discussion compares number-needed-to-treat across adherence studies (Márquez, Tortajada, Raigal) but says nothing about the delivery channels used across mobile-health research. (LLM, conf=0.65)
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“A systematic review by Marshall et al. in 16 countries revealed that the lack of awareness of the causes and symptoms of hypertension, fear of the drugs’ side effects, and their dependency are the major causes of treatment discontinuation and lack of adherence to treatment [35, 36].”
§ The effect of the mobile “blood pressure management application” on hypertension self-management enhancement: a randomized controlled trial > Discussion
What the sources say
- Partly supportedcites [35] Kumar K, Greenfield S, Raza K, Gill P, Stack R. Understanding adherence-related beliefs about medicine amongst patients of South Asian origin with diabetes and cardiovascular disease patients: a qualitative synthesis. BMC Endocr Disord. 2016;16(1):1. sourceExperimental — accuracy not yet measured
In the Discussion (p. n/a) our copy does report Marshall et al.'s systematic review (ref [50], Marshall, Wolfe & McKevitt, BMJ 2012, 'Lay perspectives on hypertension and drug adherence') and attributes to it patient views on the need for and efficacy of medicines, intentional non-adherence, toxicity of medicines/polypharmacy and the necessity of traditional remedies — which supports the 'fear of drug side effects' element. However, it never states '16 countries' (it lists nine, 'countries including the USA, UK, Brazil, Sweden, Canada, Finland, Netherlands, South Korea and Spain'), never mentions dependency on medicines as a cause of discontinuation, and frames awareness differently: the review found that hypertensive patients with HIGH adherence had an understanding of hypertension mapping onto the biomedical model, rather than stating lack of awareness of causes/symptoms as a major cause of treatment discontinuation. (LLM, conf=0.68)
- Not checked yetcites [36] Marshall IJ, Wolfe CD, McKevitt C. Lay perspectives on hypertension and drug adherence: systematic review of qualitative research; 2012.
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Partly supported
23 more claims
Create a free account to see all 56 claims and to verify the 22 references still open.
- It may state two separate claims as one. 12
- The quote only partly states this claim. 2
- Probably not a substantial claim. 20
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
Each contradiction between two passages listed here was confirmed by an independent check.
Rated major: it would touch a result — a value a result rests on, reported and recomputed p-values on opposite sides of the significance level, two passages that conflict with no sign which is right, or a cited work retracted before this paper was published.
In the paper
§ The effect of the mobile “blood pressure management application” on hypertension self-management enhancement: a randomized controlled trial > Results
“| Characteristics | Adherence to a low-fat diet (mean ± SD) 2* | 12.6 ± 5.1 | 15.8 ± 3.3 |”
§ The effect of the mobile “blood pressure management application” on hypertension self-management enhancement: a randomized controlled trial > Results
“| Adherence to low-fat diet* | Intervention group | 16.0 ± 3.0 | 17.86 ± 1.06 | 18.21 ± 0.78 | 1.7 (1.3–2.1) |”
Rated minor: it would not touch a result — a value no result rests on, a p-value that stays on the same side of the significance level, or a conflict that is clerical, resolved elsewhere in the paper, or outside its own findings.
In the paper
§ The effect of the mobile “blood pressure management application” on hypertension self-management enhancement: a randomized controlled trial > Abstract > Results
“Moreover, moderate physical activity increased to 100.0 min (95% CI 61.7–138.3) per week in the intervention group.”
§ The effect of the mobile “blood pressure management application” on hypertension self-management enhancement: a randomized controlled trial > Results
“The estimated mean of moderate physical activity over the study period was 247.3 (95% CI 223.7–267.5) in the intervention group and 102.7 (95% CI 100.4–176.8) in the control group, indicating an increase of 100.0 min per week (95% CI 61.7–138.3) in the intervention group.”
Rated minor: it would not touch a result — a value no result rests on, a p-value that stays on the same side of the significance level, or a conflict that is clerical, resolved elsewhere in the paper, or outside its own findings.
In the paper
“| Demographic | • Diploma | 33 (56.7) | 26 (43.3) |”
§ The effect of the mobile “blood pressure management application” on hypertension self-management enhancement: a randomized controlled trial > Results
Reported 56.7 · recomputed 55
Rated minor: it would not touch a result — a value no result rests on, a p-value that stays on the same side of the significance level, or a conflict that is clerical, resolved elsewhere in the paper, or outside its own findings.
In the paper
§ The effect of the mobile “blood pressure management application” on hypertension self-management enhancement: a randomized controlled trial > Results
“| Characteristics | Vigorous physical activity (mean ± SD) 4* | 170.0 ± 87.4 | 162.0 ± 100/8 |”
§ The effect of the mobile “blood pressure management application” on hypertension self-management enhancement: a randomized controlled trial > Results
“4* (range 0–150 min/week)”
Citations
Cites
James, P. A., Oparil, S., Carter, B. L., Cushman, W. C., Dennison-Himmelfarb, C., Handler, J., Lackland, D. T., LeFevre, M. L., MacKenzie, T. D., Ogedegbe, O., et al. (2014) · JAMA · doi:10.1001/jama.2013.284427 · Cited by 7,950
Ettehad, D., Emdin, C. A., Kiran, A., Anderson, S. G., Callender, T., Emberson, J., Chalmers, J., Rodgers, A., & Rahimi, K. (2016) · The Lancet · doi:10.1016/s0140-6736(15)01225-8 · Cited by 3,755
Global Burden of Hypertension and Systolic Blood Pressure of at Least 110 to 115 mm Hg, 1990-2015
Forouzanfar, M. H., Liu, P., Roth, G. A., Ng, M., Biryukov, S., Marczak, L., Alexander, L., Estep, K., Hassen Abate, K., Akinyemiju, T. F., et al. (2017) · JAMA · doi:10.1001/jama.2016.19043 · Cited by 2,381
Development of the World Health Organization Global Physical Activity Questionnaire (GPAQ)
Armstrong, T., & Bull, F. (2006) · Journal of Public Health · doi:10.1007/s10389-006-0024-x · Cited by 1,727
Health Program Planning: An Educational and Ecological Approach
Green, L. W., & Kreuter, M. W. (1991) · Cited by 1,332
Mobile Health Technology Evaluation
Kumar, S., Nilsen, W. J., Abernethy, A., Atienza, A., Patrick, K., Pavel, M., Riley, W. T., Shar, A., Spring, B., Spruijt-Metz, D., et al. (2013) · American Journal of Preventive Medicine · doi:10.1016/j.amepre.2013.03.017 · Cited by 900
Lackland, D. T., Roccella, E. J., Deutsch, A. F., Fornage, M., George, M. G., Howard, G., Kissela, B. M., Kittner, S. J., Lichtman, J. H., Lisabeth, L. D., et al. (2014) · Stroke · doi:10.1161/01.str.0000437068.30550.cf · Cited by 815
James, P. A., Oparil, S., Carter, B. L., Cushman, W. C., Himmelfarb, C. D., Handler, J., Lackland, D. T., LeFevre, M. L., MacKenzie, T. D., Ogedegbe, O., et al. (2014) · Carolina Digital Repository (University of North Carolina at Chapel Hill) · Cited by 705
BMC Medical Informatics and Decision Making
McConnell, P. I., Dash, R., Chilukuri, R., Pietrobon, R. S., Johnson, K. S., Annechiarico, R. P., & Cuticchia, A. J. (2008) · Cited by 678
Siervo, M., Lara, J., Chowdhury, S., Ashor, A., Oggioni, C., & Mathers, J. C. (2015) · British Journal of Nutrition · doi:10.1017/s0007114514003341 · Cited by 656
Cited by
Zangger, G., Bricca, A., Liaghat, B., Juhl, C. B., Mortensen, S. R., Andersen, R. M., Damsted, C., Hamborg, T. G., Ried-Larsen, M., Tang, L. H., et al. (2023) · Journal of Medical Internet Research · doi:10.2196/46439 · Cited by 116
Digital Therapeutics in Hypertension: Evidence and Perspectives
Kario, K., Harada, N., & Okura, A. (2022) · Hypertension · doi:10.1161/hypertensionaha.122.19414 · Cited by 109
Boima, V., Doku, A., Agyekum, F., Tuglo, L. S., & Agyemang, C. (2024) · EClinicalMedicine · doi:10.1016/j.eclinm.2024.102432 · Cited by 82
“The meta-analysis of continuous outcome measurements for PA in 2 studies showed signi fi cant differences in the intervention [SMD = 1.30; (95% CI 0.23 – 2.37); p = 0.02; n = 276] compared to the control group, 25,33 (Fig.”
BackgroundResultInfluentialAkinola, S., & Telukdarie, A. (2023) · Sustainability · doi:10.3390/su151310417 · Cited by 70
“[79] 28 Blockchain Technology Provides a secure and tamper-proof platform for the storage and sharing of health information, enhancing privacy and security and supporting interoperability across different health information systems [80]”
BackgroundSeid, A., Fufa, D. D., & Bitew, Z. W. (2024) · Frontiers in Digital Health · doi:10.3389/fdgth.2024.1282570 · Cited by 54
Metadata
- Authors
- Bozorgi, A., Hosseini, H., Eftekhar, H., Majdzadeh, R., Yoonessi, A., Ramezankhani, A., Mansouri, M., & Ashoorkhani, M.
- Affiliations
- Tehran Heart Center (IR)
- Tehran University of Medical Sciences (IR)
- Payame Noor University (IR)
- Corresponding author
- Ashoorkhani, Mahnaz
- ORCID
- Venue
- Trials
- Published
- 2021-06-24
- Volume
- 22
- Issue
- 1
- Pages
- 413-413
- ISSN
- 1745-6215 (ISSN-L)
- PMC
- PMC8223338
- OpenAlex
- W3111671800
- Cited by
- 94
- References
- 34
- Citations by year
- 2026: 9 · 2025: 15 · 2024: 40 · 2023: 18 · 2022: 11 · 2021: 1
- FWCI
- 19.66
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- cc-by
- creativecommons.org/licenses/by/4.0 (tdm)
- creativecommons.org/licenses/by/4.0 (vor)
- Locations
- Trials (publishedVersion, cc-by)
- Research Square (acceptedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Open Access at Essex (University of Essex) (acceptedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Funders
- The Global Oper Reserch Support Team (00990476)
- Topics
- Health Sciences › Health Professions › General Health Professions › Mobile Health and mHealth Applications
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Blood Pressure and Hypertension Studies
- Health Sciences › Medicine › Family Practice › Medication Adherence and Compliance
- Keywords
- hypertension, self-management, mobile health, mobile health apps, medication adherence, DASH diet, blood pressure monitoring, physical activity, smartphone-based intervention
- MeSH terms
- Self-Management, Blood Pressure, Humans, Hypertension, Iran, Medication Adherence, Mobile Applications
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
The claim verdicts this report counts are experimental: their accuracy is not yet measured.
A language model drew the claims from the paper on 2026-09-30, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).
A second model labelled each claim on 2026-09-30 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).
Cited sources are checked with a language model’s help (qwen3.8-omni-flash and gpt-6-sol).
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: The effect of the mobile “blood pressure management application” on hypertension self-management enhancement: a randomized controlled trial. https://app.cochat.ai/papers/10.1186/s13063-021-05270-0
- The paper
- Bozorgi, A., Hosseini, H., Eftekhar, H., Majdzadeh, R., Yoonessi, A., Ramezankhani, A., Mansouri, M., & Ashoorkhani, M. (2021). The effect of the mobile “blood pressure management application” on hypertension self-management enhancement: a randomized controlled trial. Trials. https://doi.org/10.1186/s13063-021-05270-0
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.
